studi
popul
includ
chines
patient
refer
huashan
hospit
fudan
univers
china
diagnosi
treatment
cryptococc
mening
volunt
studi
approv
local
medic
ethic
committe
inform
consent
obtain
particip
definit
diagnosi
cryptococc
mening
made
patient
met
least
follow
criteria
cultur
posit
c
neoforman
cerebrospin
fluid
csf
posit
result
csf
india
ink
smear
centrifug
sediment
cryptococcu
compat
histopatholog
find
encapsul
yeast
observ
brain
tissu
probabl
cryptococc
mening
diagnos
patient
present
clinic
syndrom
mening
posit
cryptococc
antigen
titer
csf
albeit
without
microbiolog
patholog
document
posit
result
test
undilut
csf
use
latexcryptococcu
antigen
detect
system
immunomycolog
consid
diagnost
api
aux
system
shanghai
use
identif
isol
lymphocyt
count
immunocompromis
condit
consid
idiopath
lymphocytopenia
predispos
host
defin
patient
immunocompromis
diseas
cirrhosi
chronic
kidney
diseas
autoimmun
diseas
diabet
mellitu
solid
malign
hematolog
malign
splenectomi
solid
organ
transplant
corticosteroid
immunosuppress
medic
idiopath
lymphocytopenia
patient
without
identifi
risk
factor
consid
immunocompet
patient
ml
venou
blood
obtain
venopunctur
genom
dna
extract
use
qiaamp
dna
kit
qiagen
accord
manufactur
instruct
six
snp
gene
includ
gc
cg
ct
codon
cgttgt
codon
ggcgac
codon
ggagaa
analyz
use
sequencingbas
type
method
brief
fragment
encompass
promot
end
exon
obtain
polymeras
chain
reaction
pcr
amplif
use
sens
antisens
primer
geneamp
pcr
system
geneamp
appli
biosystem
reaction
perform
dna
total
volum
contain
master
contain
mmoll
mmoll
dntp
proofread
dna
polymeras
buffer
sangon
biotech
primer
cycl
condit
min
cycl
min
five
microlit
result
pcr
treat
fluoresc
chemiluminesc
visibl
imag
system
subject
direct
sequenc
accord
previou
studi
document
abil
mbl
product
determin
mbl
genotyp
particip
classifi
follow
group
base
genotyp
high
produc
low
produc
defici
mutat
homozygos
compound
heterozygos
oo
associ
mbl
defici
mbl
level
measur
patient
control
subject
use
mannanco
commerci
enzymelink
immunosorb
assay
kit
antimbl
antibodi
recogn
function
oligom
hycult
biotechnolog
purpos
valid
correl
genotyp
group
serum
mbl
level
insuffici
sampl
avail
test
correl
mbl
level
cryptococc
mening
assay
perform
accord
instruct
provid
manufactur
eight
standard
mbl
concentr
ngml
prepar
dilut
human
mbl
standard
ngml
provid
kit
assay
simultan
analys
use
individu
snp
test
deviat
hardyweinberg
equilibrium
differ
gene
polymorph
distribut
patient
control
subject
background
characterist
analyz
fisher
exact
test
odd
ratio
or
confid
interv
ci
also
determin
differ
mbl
plasma
concentr
among
high
low
deficientproduc
mbl
group
analyz
use
analysi
varianc
anova
report
p
valu
signific
level
use
stata
softwar
version
stata
use
statist
analysi
total
hivuninfect
patient
cryptococc
mening
includ
proven
diagnosi
probabl
diagnosi
sixtytwo
patient
male
age
rang
patient
year
median
year
ten
volunt
exclud
analysi
predispos
diseas
diabet
mellitu
solid
malign
one
hundr
nineteen
control
subject
male
age
rang
year
median
year
healthi
control
subject
predispos
condit
diabet
mellitu
solid
malign
corticosteroid
usag
lymphocyt
count
uncheck
patient
control
subject
chines
han
ethnic
demograph
characterist
predispos
factor
clinic
inform
patient
summar
tabl
distribut
genotyp
carriag
rate
allel
haplotyp
frequenc
polymorph
test
frequenc
allel
control
group
verifi
accord
expect
hardyweinberg
equilibrium
patient
cryptococc
mening
gene
frequenc
exon
variant
allel
b
c
allel
identifi
frequenc
promot
site
h
l
promot
site
x
p
q
frequenc
hypa
lyqa
lypa
lxpa
lypb
hypd
haplotyp
respect
lyqc
haplotyp
identifi
hand
among
control
subject
gene
frequenc
exon
variant
b
allel
respect
c
allel
identifi
gene
frequenc
upstream
variant
h
l
x
p
q
allel
respect
frequenc
hypa
lyqa
lypa
lxpa
lypb
haplotyp
respect
mbl
plasma
concentr
particip
measur
mean
level
ngml
rang
ngml
highproduc
mbl
genotyp
group
ngml
rang
ngml
lowproduc
group
ngml
rang
ngml
mbldefici
genotyp
group
statist
signific
differ
among
group
anova
p
verifi
genotyp
consist
mbl
plasma
concentr
homozyg
mut
genotyp
oo
code
region
detect
patient
immunocompet
patient
control
subject
tabl
oo
genotyp
associ
cryptococc
mening
patient
vs
control
subject
p
ci
correl
overt
immunocompet
patient
patient
vs
control
subject
p
ci
control
group
proport
mbl
genotyp
correl
high
low
defici
mbl
level
respect
proport
mbl
genotyp
associ
high
low
defici
plasma
mbl
level
respect
patient
cryptococc
mening
respect
immunocompet
patient
although
found
differ
distribut
high
low
mblproduc
group
patient
control
subject
defici
mblproduc
genotyp
associ
cryptococc
mening
p
ci
particularli
patient
without
immunocompromis
underli
diseas
p
ci
tabl
mbl
polymorph
distribut
investig
chines
popul
studi
show
distribut
mbl
genotyp
consist
studi
chines
han
popul
found
c
allel
person
allel
identifi
studi
individu
find
compar
report
c
allel
allel
white
popul
indic
proport
mbl
genotyp
associ
defici
plasma
mbl
level
white
popul
might
higher
chines
han
popul
proport
previous
healthi
patient
cryptococc
mening
vari
greatli
region
region
among
hivuninfect
patient
popul
data
america
franc
thailand
seri
show
rel
low
proport
previous
healthi
host
rang
major
patient
underli
condit
howev
high
percentag
previous
healthi
host
among
hivuninfect
patient
cryptococc
mening
report
region
recent
epidemiolog
studi
reveal
patient
without
aid
cryptococc
mening
without
predispos
factor
although
role
ethnic
factor
suscept
diseas
still
unclear
previous
healthi
patient
cryptococcosi
countri
render
opportun
us
studi
genet
suscept
factor
diseas
result
show
homozyg
variant
genotyp
oo
associ
risk
cryptococc
mening
proport
defici
mblproduc
genotyp
patient
cryptococc
mening
significantli
higher
control
group
indic
mbl
defici
may
one
predispos
factor
cryptococc
mening
report
admittedli
predisposit
present
hivuninfect
patient
cryptococcosi
differ
also
present
subgroup
patient
without
immunocompromis
factor
therefor
genet
defect
mbl
may
provid
one
answer
mysteri
appar
immunocompet
patient
develop
cryptococc
mening
eisen
et
al
found
statist
signific
differ
proport
mbl
genotyp
laxo
oo
associ
defici
plasma
mbl
level
genotyp
noncompromis
patient
cryptococcosi
normal
control
subject
vs
addit
author
find
increas
proport
patient
cryptococcosi
plasma
mbl
level
ngml
vs
apart
rel
small
sampl
size
differ
ethnic
popul
australian
versu
chines
cryptococcu
strain
may
explain
inconsist
result
studi
patient
cryptococc
mening
infect
cryptococcu
gattii
c
neoforman
australia
predominantli
c
neoforman
china
valid
studi
need
examin
result
current
studi
mbl
one
protein
complement
system
import
constitu
innat
immun
system
mbl
modifi
effici
uptak
express
phagocyt
receptor
research
past
decad
indic
mbl
provid
distinct
third
pathway
complement
activ
mbl
play
role
host
defens
pathogen
strain
fungu
c
neoforman
known
resist
mbl
bind
protect
polysaccharid
capsul
solubl
mbl
bind
acapsular
c
neoforman
panepinto
et
al
also
demonstr
mbl
bind
c
neoforman
mutant
defect
cell
integr
encapsul
wildtyp
strain
vitro
observ
acapsular
mutant
c
neoforman
appear
surfac
mblbind
mannoprotein
present
encapsular
cell
surfac
howev
suggest
solid
phase
mbl
increas
bind
encapsul
c
neoforman
monocyt
neutrophil
monocytederiv
macrophag
although
biolog
signific
solidphas
mbl
mechan
improv
c
neoforman
bind
phagocyt
remain
unclear
studi
first
knowledg
show
mbl
defici
associ
cryptococc
mening
particularli
nonimmunocompromis
host
although
mbl
may
play
import
role
small
proport
patient
cryptococc
mening
cryptococcosi
complex
diseas
genet
predispos
factor
environment
factor
must
also
explain
infect
previous
healthi
person
